Streamlining Hematology Prior Authorization with Da Vinci PAS

The Challenge of Hematology Prior Authorization

Prior authorization in hematology frequently involves high-cost specialty drugs and complex procedures, such as factor concentrates for hemophilia, novel therapeutics for sickle cell disease, and CAR-T cell therapies for hematologic malignancies. These cases demand extensive clinical documentation, often guided by ASH guidelines and NCCN criteria, to justify medical necessity. Common denial reasons stem from gaps in NCCN compendium alignment for novel agents or specific criteria for prophylaxis vs. on-demand factor use.

Leveraging Da Vinci PAS for Hematology Workflows

The HL7 Da Vinci Prior Authorization Support (PAS) Implementation Guide provides a standardized FHIR-based framework for prior authorization. This standard replaces fragmented, payer-specific submission methods with a uniform interface, enabling structured data exchange. For hematology, this means moving beyond unstructured PDF attachments to submitting precise clinical documentation as FHIR resources, directly supporting payer-side automated review and faster decision-making.

Klivira's Da Vinci PAS Workflow for Hematology

Klivira's platform integrates Da Vinci PAS conformance to automate prior authorization specific to hematology's unique demands. At order entry, our Da Vinci CRD (Coverage Requirements Discovery) integration with EMRs identifies PA requirements for high-volume categories like factor concentrates, sickle cell specialty drugs, and specialty imaging. For documentation assembly, Da Vinci DTR (Documentation Templates and Rules) drives the collection of structured clinical data, pre-populating forms with EMR FHIR data relevant to ASH or NCCN guidelines, such as factor levels or prior-line therapies for CAR-T.

Key Benefits for Hematology Practices

• **Structured Documentation:** Replaces manual data entry and unstructured attachments with FHIR-native clinical documentation, reducing errors and enabling automated payer review.
• **Accelerated Turnaround:** Standardized Da Vinci PAS submissions facilitate faster processing and decision times, critical for time-sensitive hematology treatments.
• **Reduced Administrative Burden:** Automates the PA workflow from discovery to submission and status tracking, freeing up prior authorization coordinators.
• **Enhanced Compliance:** Prepares practices for upcoming CMS-0057-F mandates by adopting FHIR-based Prior Authorization APIs, improving transparency and efficiency.
• **Intelligent Routing:** Klivira intelligently routes submissions via Da Vinci PAS where available, falling back to X12 278 or payer portals for non-conformant payers, ensuring continuity.

Navigating Payer Conformance and Legacy Systems

While Da Vinci PAS represents the future of prior authorization, payer adoption is phased. Klivira's platform accounts for this by providing dynamic routing: submitting via Da Vinci PAS for conformant payers and seamlessly falling back to X12 278 EDI or payer-specific portals for others. We track payer conformance, including those impacted by CMS-0057-F, to ensure your hematology practice is always leveraging the most efficient submission channel available.